James P. Tursi, M.D.
Board Member
MetaVia Inc. (MTVA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James P. Tursi, M.D.
James P. Tursi, M.D. is recorded as Board Member at MetaVia Inc. (MTVA). MetaVia Inc. reported in an 8-K filed June 8, 2026 that James P. Tursi, M.D. was appointed Class I director, effective June 8, 2026. MetaVia Inc. reported in an 8-K filed November 6, 2023 that James P. Tursi, M.D. was appointed Class I director, effective November 1, 2023.
“D. Gordon Strickland and James P. Tursi, M.D. were elected as Class I directors to serve until the 2029 annual meeting of stockholders.”
“On November 1, 2023, the Board of Directors (the "Board") of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the "Company"), on the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), appointed James P. Tursi, M.D., effective immediately, to serve as a Class I director to hold office for a term expiring at the Company's 2026 annual meeting of the Company's stockholders, which is the next stockholder meeting at which Class I directors will be elected.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-08–present
-
MetaVia Inc. (MTVA)
SEC 8-K
Current2023-11-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MetaVia Inc.
Other people whose current roles at this company are on record from its filings.
- Ben Gil Price CEO
- Hyung Heon Kim CEO, CFO, Chief Accounting Officer, Board Member
- Joseph Hooker CEO, CFO, Chief Accounting Officer
- Richard Kang CEO
- Douglas J. Swirsky Chairman, Board Member
- Marshall H. Woodworth CFO, Chief Accounting Officer
- Marshall Woodworth CFO
- Akash Bakshi COO
- Andrew Koven Board Member
- D. Gordon Strickland Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.